Labrador, Aldrin L.

HRN: 04-15-50  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CEFUROXIME 750MG (VIAL)
03/22/2026
03/28/2026
IV
750mg
Q8
ATP
Checking Initial Appropriateness 
03/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/23/2026
03/23/2026
IV
4.5g
Loading Dose
Cap-hr
Checking Initial Appropriateness 
03/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/23/2026
03/29/2026
IV
2.25g
Q8h
CAP-HR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: